Maxocol – 5 mg/5 ml Syrup
Dosage : Syrup
Strength : 5 mg/5 ml
Generic : Metoclopramide Hydrochloride
Pack Size : 1 Pack = NA
Manufacturer : Medimet Pharmaceuticals Ltd.
- ডেলিভারি সময়০১ - ৪৮ ঘন্টার মধ্যে হোম ডেলিভারি
- ডেলিভারি চার্জ ৯৯৯ বা তার বেশি অর্ডার করলেই পাবেন ফ্রি হোম ডেলিভারি (ডেলিভারি চার্জ মাত্র ২৫/- টাকা)
- যদি প্রস্তুতকারক পণ্য সরবরাহ করতে না পারে, তবে সরবরাহে বিলম্ব হতে পারে বা অর্ডার বাতিল হতে পারে।
- ক্ষতিগ্রস্ত বা মেয়াদোত্তীর্ণ পণ্য ফেরত: ক্ষতিগ্রস্ত বা মেয়াদোত্তীর্ণ পণ্য বিনামূল্যে ফেরত দেওয়ার সুবিধা।
- Day and night customer service
Description
Adults less than 65 years of age: The recommended dosage is 1 spray (15 mg) in one nostril, 30 minutes before each meal and at bedtime (maximum of 4 sprays daily) for 2 to 8 weeks, depending on symptomatic response.
Adults 65 years of age and older: Metoclopramide is not recommended in geriatric patients as initial therapy. Geriatric patients receiving an alternative metoclopramide product at a stable dosage of 10 mg four times daily can be switched to Metoclopramide 1 spray (15 mg) in one nostril, 30 minutes before each meal and at bedtime (maximum four times daily) for 2 to 8 weeks, depending on symptomatic response.
Metoclopramide tablet:
Gastroesophageal Reflux: Administer Metoclopramide continuously or intermittently:
- Continuous: Administer 10 to 15 mg, 30 minutes before each meal and at bedtime (maximum of 60 mg per day) for 4 to 12 weeks.
- Intermittent: Single doses up to 20 mg prior to provoking situation.
Acute and Recurrent Diabetic Gastroparesis: Administer 10 mg, 30 minutes before each meal and at bedtime (maximum of 40 mg per day) for 2 to 8 weeks.
Metoclopramide injection:
For the Relief of Symptoms Associated with Diabetic Gastroparesis (Diabetic Gastric Stasis): If only the earliest manifestations of diabetic gastric stasis are present, oral administration of metoclopramide may be initiated. However, if severe symptoms are present, therapy should begin with Metoclopramide Injection (IM or IV). Doses of 10 mg may be administered slowly by the intravenous route over a 1- to 2-minute period. Administration of Metoclopramide Injection (metoclopramide injection, USP) up to 10 days may be required before symptoms subside, at which time oral administration of metoclopramide may be instituted. The physician should make a thorough assessment of the risks and benefits prior to prescribing further metoclopramide treatment.
For the Prevention of Nausea and Vomiting Associated with Emetogenic Cancer Chemotherapy: Intravenous infusions should be made slowly over a period of not less than 15 minutes, 30 minutes before beginning cancer chemotherapy and repeated every 2 hours for two doses, then every 3 hours for three doses. The initial two doses should be 2 mg/kg if highly emetogenic drugs such as cisplatin or dacarbazine are used alone or in combination. For less emetogenic regimens, 1 mg/kg per dose may be adequate.
For the Prevention of Postoperative Nausea and Vomiting: Metoclopramide Injection should be given intramuscularly near the end of surgery. The usual adult dose is 10 mg; however, doses of 20 mg may be used.
Reviews
There are no reviews yet.